Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients

American Journal of Gastroenterology

Volumn 94, Issue 2, 1999, Pages 334-338

  Sturniolo, Giacomo Carlo ^a,c   Mestriner, Cinzia ^a   Irato, Paola ^b   Albergoni, Vincenzo ^b   Longo, Giuseppe ^a   D'Incà, Renata ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; FERRITIN; IRON; METALLOTHIONEIN; PENICILLAMINE; TRACE ELEMENT; TRANSFERRIN; ZINC; ZINC SULFATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DUODENITIS; DUODENUM BIOPSY; DUODENUM MUCOSA; DYSPEPSIA; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE ABSORPTION; INTESTINE CELL; MALE; PRIORITY JOURNAL; WILSON DISEASE;

ADULT; CASE-CONTROL STUDIES; CHELATING AGENTS; COPPER; DUODENITIS; DUODENUM; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; INTESTINAL MUCOSA; IRON; MALE; METALLOTHIONEIN; PENICILLAMINE; ZINC SULFATE;

EID: 0033082985     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.851_w.x     Document Type: Article

References (29)

1. Chu NS, Hung TP. Geographic variations in Wilson's disease. J Neurol Sci 1993;1177l-7.
2. Bull PC, Thomas GR, Rommens JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-37.
3. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-50.
4. Nartey NO, Frei JV, Cherian MG. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration). Lab Invest 1987;57:397-40I.
5. Hunziker PE, Sternlieb I. Copper metallothionein in patients with hepatic copper overload. Eur J Clin Invest 1991:21:466-1.
6. Walshe JM. Penicillamine: A new oral therapy for Wilson's disease. Am JMed 1956:21:487-95.
7. Hall AC, Young B\V, Bremner I. Intestinal metallothionein and the mutual antagonism between copper and zinc in the rat. J Inorg Biochem 1979:11:57-66.
8. Van Campen DR. Effects of zinc, cadmium, silver and mercury on the absorption and distribution of Cu-64 in rats. J Nutr 1966;88:125-130.
9. Cousins RJ. Absorption, transport and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin. Physiol Rev 1985:65:238-309.
10. Yuzbasiyan-Gurkan V, Grider A, Nostrant T, et al. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 1992;120:380-6.
11. Fischer PWF, Giroux A, L'Abbé MR. The effect of dietary zinc on intestinal copper absorption. Am J Clin Nutr 1981:34:1670-5.
12. Irato P, Sturniolo GC, Giacon G, et al. Effect of zinc supplementation on metallothionein, copper, and zinc concentration in various tissues of copper-loaded rats. Biol Trace Elem Res 1996:51:87-96.
13. Kägi JHR. Evolution, structure and chemical activity of class I metallothioneins: an overview. In: Suzuki KT, Inuira N, Kimura M, eds. Metallothionein III. Basel: Birkauser Verlag Basel, 1993:29-55.
14. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, et al. Treatment of Wilson's disease with zinc XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994;123:849-58.
15. Kato J, Kobune M, Kohgo Y, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon Rats. J Clin Invest 1996;98:923-9.
16. Scheuhammer AM, Cherian MG. Quantification of metallothionein by silver saturation. Method Enzymol 1991;205:78-83.
17. Onosaka S, Cherian MG. Comparison of metallothionein determination by polarographic and cadmium-saturation methods. Toxicol Appl Pharm 1982;63:270-4.
18. Lowry OH, Rosebrough NJ, Fair AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951:193:265-75.
19. Dawson JB, Walker BE. Direct determination of zinc in whole blood, plasma and urine by atomic absorption spectroscopy. Clin Chim Acta 1962:26:465-75.
20. Brewer GJ, Hill GM, Prasad AS, et al. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:3I4-20.
21. Rossaro L, Sturniolo GC, Giacon G, et al. Zinc therapy in Wilson's disease: Observations in five patients. Am J Gastroenterol 1990;85: 665-8.
22. Hoogenraad TU, Van Hattum J, Van den Hamer CJA. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987:77:137-46.
23. Sturniolo GC, D'lnca R, Lecis PE, et al. Neutron activation analysis efficiently measures the concentration of trace elements in endoscopie biopsies from the normal and inflamed human colon. J Trace Elem Exp Med 1997:10:217-24.
24. Yuan DS, Stearman R, Dancis A, et al. The MenkesAVilson disease gene Homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake. Proc Nat Acad Sci USA 1995;92: 2632-6.
25. Harris ZL, Takahashi Y, Miyajima H, et al. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995;92:2539-43.
26. Sokol RJ. Copper storage diseases. In: Kaplowitz N. Liver and biliary diseases. Baltimore: Williams and Wilkins, 1992:322-33.
27. Young IS, Trouton TG, Torney JJ. Antioxidant status and lipid peroxidation in hereditary haemocromatosis. Free Rad Biol Med 1994; 16:393-7.
28. Niemala O, Parkkila S, Britton RS. Hepatic lipid peroxidation in patients with hereditary haemocromatosis. Hepatology 1995;22:372A.
29. Sokol RJ, Twedt D, McKim JM. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994:107:1788-98.